Nichi-Iko Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nichi-Iko Pharmaceutical Company Limited with three other
companies in this sector in Japan:
Kobayashi Pharmaceutical Co Ltd
sales of 137.21 billion Japanese Yen [US$1.23 billion]
of which 78%
was Domestic Manufacture And Sale Of Househo),
Ono Pharmaceutical Co Ltd
(160.28 billion Japanese Yen [US$1.43 billion]
of which 31%
was Metabolic Medicine And Vitamin compound), and
Sawai Pharmaceutical Co., Ltd.
(123.49 billion Japanese Yen [US$1.11 billion]
of which 100%
was Pharmaceutical Business).
Nichi-Iko Pharmaceutical Company Limited reported sales of ¥143.51 billion (US$1.28 billion)
March of 2016.
increase of 13.0%
versus 2015, when the company's sales were ¥127.02 billion.
Sales at Nichi-Iko Pharmaceutical Company Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 85%).